Clinical Trial Update: A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF

View source ↗

Summary

A completed prospective non-concurrent controlled evaluation comparing open surgery with MAS® PLIF for Lumbar Degenerative Disc Disease. The sponsor is NuVasive…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lumbar Degenerative Disc Disease

Drugs mentioned

• MAS® PLIF

Snippet

Sponsor: NuVasive | Conditions: Lumbar Degenerative Disc Disease | Status: COMPLETED